Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.421 USD | +2.23% | -2.55% | -8.50% |
03-20 | UBS Adjusts Singular Genomics Systems Price Target to $0.50 From $0.40, Maintains Neutral Rating | MT |
03-18 | Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.50% | 30.51M | |
+26.01% | 44.96B | |
+0.22% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.50% | 26.08B | |
-20.96% | 19.03B | |
+6.75% | 12.75B | |
+28.81% | 12.06B | |
-3.78% | 11.75B |
- Stock Market
- Equities
- OMIC Stock
- News Singular Genomics Systems, Inc.
- Earnings Flash (OMIC) SINGULAR GENOMICS SYSTEMS Posts Q4 Revenue $1.1M, vs. Street Est of $1.04M